Clinical Trials Browser

Phase 2 × Lymphoma × carfilzomib × Clear all

NCT02042950 2019-05-01

A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

Phase 2 Terminated

6 enrolled 6 charts

Lymphoma, Recurrence, Lymphoma, Mantle-Cell